279 related articles for article (PubMed ID: 9017770)
41. Response of blood pressure, cardiac output, peripheral resistance, and exercise performance to substitution of calcium blocker for beta-blocker plus thiazide diuretic therapy in patients with both systemic hypertension and mild stable angina.
Kawanishi DT; Reid CL; Gonzales A; O'Rourke RA; Rahimtoola SH
Circulation; 1989 Dec; 80(6 Suppl):IV162-70. PubMed ID: 2574640
[TBL] [Abstract][Full Text] [Related]
42. Combined enalapril and felodipine extended release (ER) for systemic hypertension. Enalapril-Felodipine ER Factorial Study Group.
Gradman AH; Cutler NR; Davis PJ; Robbins JA; Weiss RJ; Wood BC
Am J Cardiol; 1997 Feb; 79(4):431-5. PubMed ID: 9052345
[TBL] [Abstract][Full Text] [Related]
43. Additive effects of diltiazem and lisinopril in the treatment of elderly patients with mild-to-moderate hypertension.
Chan P; Lin CN; Tomlinson B; Lin TH; Lee YS
Am J Hypertens; 1997 Jul; 10(7 Pt 1):743-9. PubMed ID: 9234828
[TBL] [Abstract][Full Text] [Related]
44. Transdermal clonidine as an adjunct to sustained-release diltiazem in the treatment of mild-to-moderate hypertension.
Lueg MC; Herron J; Zellner S
Clin Ther; 1991; 13(4):471-81. PubMed ID: 1933999
[TBL] [Abstract][Full Text] [Related]
45. Efficacy and tolerability of enalapril and sustained-release verapamil in older patients with mild to moderate essential hypertension.
Weir MR; Cassidy CA; Hall PS; Lancaster A; Schubert C; Urick A; Saunders E; Kong BW; Jenkins P; Lavin PT
Clin Ther; 1990; 12(2):139-48. PubMed ID: 2354483
[TBL] [Abstract][Full Text] [Related]
46. Nitrendipine and enalapril combination therapy in mild to moderate hypertension: assessment of dose-response relationship by a clinical trial of factorial design.
Roca-Cusachs A; Torres F; Horas M; Ríos J; Calvo G; Delgadillo J; Terán M;
J Cardiovasc Pharmacol; 2001 Dec; 38(6):840-9. PubMed ID: 11707687
[TBL] [Abstract][Full Text] [Related]
47. Effectiveness and tolerability of fixed-dose combination enalapril plus nitrendipine in hypertensive patients: results of the 3-month observational, post-marketing, multicentre, prospective CENIT study.
Sierra A; Roca-Cusachs A; Redón J; Marín R; Luque M; Figuera M; Garcia-Garcia M; Falkon L
Clin Drug Investig; 2009; 29(7):459-469. PubMed ID: 19499963
[TBL] [Abstract][Full Text] [Related]
48. The efficacy and safety of enalapril in moderate to severe essential hypertension.
Walker JF; Kulaga SF; Kramsch DM
J Hypertens Suppl; 1984 Dec; 2(2):S107-11. PubMed ID: 6100871
[TBL] [Abstract][Full Text] [Related]
49. Enalapril as first choice treatment of mild, moderate and severe essential hypertension: results of an open multicentre clinical trial. New Zealand Hypertension Study Group.
N Z Med J; 1987 Mar; 100(819):137-9. PubMed ID: 2837697
[TBL] [Abstract][Full Text] [Related]
50. Imidapril hydrochloride in essential hypertension: a double-blind comparative study using enalapril maleate as a control.
Saruta T; Omae T; Kuramochi M; Iimura O; Yoshinaga K; Abe K; Ishii M; Watanabe T; Takeda T; Ito K
J Hypertens Suppl; 1995 Sep; 13(3):523-30. PubMed ID: 8592249
[TBL] [Abstract][Full Text] [Related]
51. Diltiazem for treatment of essential hypertension: a double-blind controlled study with reserpine.
Ogawa K; Ban M; Ito T; Watanabe T; Kobayashi T; Yamazaki N; Suzuki Y
Clin Ther; 1984; 6(6):844-53. PubMed ID: 6391669
[TBL] [Abstract][Full Text] [Related]
52. Antihypertensive monotherapy with nisoldipine CC is superior to enalapril in black patients with severe hypertension.
Radevski I; Skudicky D; Candy G; Sathekge S; Strugo V; Sareli P
Am J Hypertens; 1999 Feb; 12(2 Pt 1):194-203. PubMed ID: 10090348
[TBL] [Abstract][Full Text] [Related]
53. A multicenter trial of enalapril in the treatment of essential hypertension.
Gavras H
Clin Ther; 1986; 9(1):24-38. PubMed ID: 3028633
[TBL] [Abstract][Full Text] [Related]
54. [Calcium antagonists vs ACE inhibitors in the treatment of essential arterial hypertension in the aged].
Cellamare G; Poppa E; Sgobba G; Bianco G
Minerva Cardioangiol; 1989 Mar; 37(3):111-8. PubMed ID: 2546102
[TBL] [Abstract][Full Text] [Related]
55. Long-term antihypertensive, metabolic and cellular effects of enalapril.
Malini PL; Strocchi E; Ambrosioni E; Magnani B
J Hypertens Suppl; 1984 Dec; 2(2):S101-5. PubMed ID: 6100870
[TBL] [Abstract][Full Text] [Related]
56. Role of the fixed-dose combination lercanidipine-enalapril in renal protection.
Egan CG; Pontremoli R
J Nephrol; 2011; 24(4):428-37. PubMed ID: 21279953
[TBL] [Abstract][Full Text] [Related]
57. Effects of enalapril on lipid profile in diabetic and non-diabetic essential hypertensive patients.
Satia MC; Shukla ML; Goyal RK
Indian J Physiol Pharmacol; 1996 Jan; 40(1):83-6. PubMed ID: 8864777
[TBL] [Abstract][Full Text] [Related]
58. Trial of slow release diltiazem for essential hypertension in general practice.
Coulter DM
N Z Med J; 1991 Feb; 104(905):37-8. PubMed ID: 1996187
[TBL] [Abstract][Full Text] [Related]
59. Effects of enalapril/lercanidipine combination on some emerging biomarkers in cardiovascular risk stratification in hypertensive patients.
Derosa G; Bonaventura A; Romano D; Bianchi L; Fogari E; D'Angelo A; Maffioli P
J Clin Pharm Ther; 2014 Jun; 39(3):277-85. PubMed ID: 24635387
[TBL] [Abstract][Full Text] [Related]
60. Comparison of two strategies for intensifying antihypertensive treatment: low-dose combination (enalapril + felodipine ER) versus increased dose of monotherapy (enalapril). LEVEL (Lexxel vs Enalapril) Study Group.
Elliott WJ; Montoro R; Smith D; Leibowitz M; Hwang C; Gradman AH; Schleman M; Klibaner M
Am J Hypertens; 1999 Jul; 12(7):691-6. PubMed ID: 10411366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
